Policy and Legislation
Court determined CMS did not act unlawfully or exceed its authority in issuing the ratings.
The bill requires PBMs to be licensed and end the practice of spread pricing, among other requirements.
Democrats are holding out on coming to a budget deal over continued subsidies for ACA plans and cuts to Medicaid.
The drugmaker will sell medications to Medicaid at most favored nation prices, the administration says.
For new submissions for review, Elsa provides a basis for pre-analysis before the normal reviewers interact with the data, says Jeff Elton of ConcertAI.
These technologies introduce new considerations regarding safety and effectiveness across the total product life cycle.
HRSA is scheduled to issue approvals to drugmakers by Oct. 15 for implementation of the pilot on Jan. 1, 2026.
The main reason for the increase is the expected end of the premium tax credits.
The deal with Pfizer will reduce the price of the company’s prescription drugs for Medicaid to Most Favored Nation pricing.
Medicare and Medicaid reimbursement will continue, but Medicaid payments are dependent on federal appropriation.